Cong candidate to file complaint with CEC against PM Modi for lies and false promises

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Bengaluru, May 23: Karnataka reported 216 covid-19 positive cases in last 24 hours, marking the highest single day spike in the state ever since the first case was detected on 8 March. 187 of these 216 patients have recently returned from Maharashtra.

A 32-year old male resident of Bengaluru died on Saturday making it the 42nd fatality in the state.

The spike on Saturday takes the total number of covid-19 positive closer to the 2,000 mark and the number of active cases to 1,307 in the state, according to the daily health bulletin of the health department.

Yadgir in northern Karnataka recorded 72 cases on Saturday while Raichur recorded 40 cases. Cases in the sugarcane growing region of Mandya continued to rise as 28 people tested positive on Saturday that takes the total number of active cases to 211 as against Bengaluru that has 124.

Gadag registered 15 cases while Bengaluru recorded 4 cases.

Most of those who tested positive on Saturday had returned from other states, especially Maharashtra, one of the worst affected regions in the country.

The spike in cases comes even as the B.S.Yediyurappa-led state government is deliberating further easing of lockdown restrictions post 31 May. The state government has already resumed public bus and train services as well to facilitate inter-district movement of people that has added to fears of spreading the virus from cities to villages where healthcare infrastructure is poor and inadequate.

Karnataka will also see domestic flight arrivals from Monday.

In a statement on Saturday, Bengaluru International Airport said that it introduced ‘Parking-to-Boarding contactless’ journey.

“We have introduced innovative contactless procedures to minimise exposure at the Airport. These enhancements demonstrate our continued commitment to keep our passengers safe in this environment," said Hari Marar, managing director and chief executive of the airport said in a statement on Saturday.